{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:11:20Z","timestamp":1790457080035,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.drugpo.2016.02.015","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T22:05:48Z","timestamp":1456351548000},"page":"178-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Implementing opioid substitution in Lebanon: Inception and challenges"],"prefix":"10.1016","volume":"31","author":[{"given":"Joseph","family":"El-Khoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale E.","family":"Nakhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Therese","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.drugpo.2016.02.015_bib0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/00952990701522674","article-title":"Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: A review of the empirical evidence","volume":"33","author":"Copenhaver","year":"2007","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.015_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550887.2011.642758","article-title":"Effect of buprenorphine dose on treatment outcome","volume":"31","author":"Fareed","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.015_bib0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drugalcdep.2011.08.021","article-title":"Prevalence and patterns of commonly abused psychoactive prescription drugs in a sample of university students from Lebanon: An opportunity for cross-cultural comparisons","volume":"121","author":"Ghandour","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0020","series-title":"The global state of harm reduction 2014","isbn-type":"print","author":"Harm Reduction International","year":"2014","ISBN":"https:\/\/id.crossref.org\/isbn\/9780992760939"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0025","series-title":"Global state of harm reduction","isbn-type":"print","author":"International Harm Reduction Association","year":"2008","ISBN":"https:\/\/id.crossref.org\/isbn\/9780955775420"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0030","series-title":"Yearly Report of Activity","author":"Internal Security Forces","year":"2010"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0035","series-title":"Yearly Report of Activity","author":"Internal Security Forces","year":"2011"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0040","series-title":"Yearly Report of Activity","author":"Internal Security Forces","year":"2012"},{"issue":"18","key":"10.1016\/j.drugpo.2016.02.015_bib0045","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0050","series-title":"Substance use and misuse in Lebanon: The Lebanon rapid situation assessment and response Study. UNODC Report","author":"Karam","year":"2003"},{"issue":"1","key":"10.1016\/j.drugpo.2016.02.015_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsat.2014.02.003","article-title":"Abuse and diversion of buprenorphine sublingual tablets and film","volume":"47","author":"Lavonas","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0065","series-title":"Opioid Substitution Program Report","author":"Ministry of Public Health","year":"2010"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0070","series-title":"Opioid Substitution Program Report","author":"Ministry of Public Health","year":"2011"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0075","series-title":"Opioid Substitution Program Report","author":"Ministry of Public Health","year":"2012"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0080","series-title":"Opioid Substitution Program Report","author":"Ministry of Public Health","year":"2013"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0115","series-title":"Opioid Substitution Program Report","author":"Ministry of Public Health","year":"2014"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0085","series-title":"Assessment of situation and response of drug use and it's harms in the Middle East and North Africa","author":"Middle East and North Africa Harm Reduction Association (MENAHRA)","year":"2012"},{"issue":"8","key":"10.1016\/j.drugpo.2016.02.015_bib0090","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/09652149835008","article-title":"Effects of readiness for drug abuse treatment on client retention and assessment of process","volume":"93","author":"Simpson","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0095","series-title":"World Drug Report (United Nations publication, Sales No. E.12.XI.1)","author":"United Nations Office on Drug and Crime","year":"2012"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0100","series-title":"World Drug Report (United Nations publication, Sales No. E.14.XI.7)","author":"United Nations Office on Drug and Crime","year":"2014"},{"key":"10.1016\/j.drugpo.2016.02.015_bib0105","series-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","author":"World Health Organization","year":"2009"},{"issue":"2","key":"10.1016\/j.drugpo.2016.02.015_bib0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2471\/BLT.12.110783","article-title":"Scaling up opioid dependence treatment in low- and middle-income settings","volume":"91","author":"Wu","year":"2013","journal-title":"Bulletin of the World Health Organization"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539591630024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539591630024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T22:51:20Z","timestamp":1536965480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095539591630024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":23,"alternative-id":["S095539591630024X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.02.015","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing opioid substitution in Lebanon: Inception and challenges","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}